Pharmail

State-of-the-Art M Lab™ Collaboration Center Opens in South Korea

We are excited to announce the opening of our new M Lab™ Collaboration Center in the Songdo district of Incheon, South Korea, one of the fastest growing biotech hubs in Asia. This new, state-of-the art center includes a simulated manufacturing environment and offers full end-to-end process development support. In addition, education on best practices and new approaches to develop, optimize and scale-up processes and simplify global technology transfer are available.

With 1,865 square meters of space and more than ten highly trained scientists and engineers, the M Lab™ Collaboration Center will serve local biopharma manufacturers, spanning the spectrum from multinational organizations to emerging companies developing biologics.

The new M Lab™ Collaboration Center in Incheon is one of nine such centers around the world. Each center allows biopharmaceutical manufacturers to explore new ways to increase productivity, improve processes and mitigate risks by giving them access to a world-class team of experts.

To continue the conversation, join us at #MLabCollaboration.

Click here for more information.

In This Same Issue

• Merck Honored with CPhI Excellence in Pharma Awards
• New Parteck® MXP Excipient for Enhanced Solubility and Stable High Drug Loads

Tweet